Home Hot keywords

Search Modes

全部
小提示: 仅限搜索简体中文结果。您可以在设置中指定搜索语言

搜索结果

gsk 1.2% Fluticasone
2021年3月8日 — 1.2 billion people are projected to be middle class – one quarter ... and Flovent experienced price pressure in the US. In the.
304 页·4 MB
2019年3月11日 — and Flonase returned to growth following a weaker allergy season ... liability of £1.2 billion, including provisions for uncertain tax ...

2006年3月1日 — xinafoate and fluticasone propionate is not due to expire until 2010 ... 1.2% of the issued share capital, were purchased and held as ...
192 页·2 MB
2020年12月1日 — Fluticasone official prescribing information for healthcare ... These events occurred in 2.9%, 1.2%, 1.0%, and 0.6% of patients, ...
2020年8月31日 — TRELEGY ELLIPTA (Fluticasone Furoate/Umeclidinium/Vilanterol Inhalation ... (GSK) and the Food and Drug Administration (FDA) agreed that the ...
23, 37, GSK, A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the treatment of seasonal allergic rhinitis, fluticasone furoate ...
2014年3月10日 — Response regarding fluticasone furoate, 1 April 2014 ... This is an important issue for patient safety and therefore for GSK.
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
“gsk 1.2% Fluticasone”的图片搜索结果
选择图片即可提供反馈
查看全部
提供反馈
GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan · TRENDING.
作者:D Bernstein2017被引用次数:5 — Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily ... clinical trials Richard Forth: Employee: GSK, Shareholder: GSK ...

google search trends